High-Profile Research and the Media: The Case of the Abio-Cor Artificial Heart
Public discussion of new medical trials is desirable, but not moment-by-moment disclosure of patients' ups and down. Nor is such disclosure necessary: the public is not entitled to all information about a trial as soon as it is available. What should be given the press, and what withheld, canno...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
2004
|
| In: |
The Hastings Center report
Year: 2004, Volume: 34, Issue: 1, Pages: 11-24 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
| Summary: | Public discussion of new medical trials is desirable, but not moment-by-moment disclosure of patients' ups and down. Nor is such disclosure necessary: the public is not entitled to all information about a trial as soon as it is available. What should be given the press, and what withheld, cannot be decided without appreciating the surprising number and intricate interrelations of the parties' needs and interests. |
|---|---|
| ISSN: | 1552-146X |
| Contains: | Enthalten in: Hastings Center, The Hastings Center report
|
| Persistent identifiers: | DOI: 10.2307/3528247 |
